Skip to content
Recall Observatory FDA recall evidence

Drug product

Nicardipine Hydrochloride Injection, 25 mg/10 ml (2.5 mg/mL),10 mL single dose vial, Rx only, Manufactured in India for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-224-10

D-0413-2015

January 23, 2015

Class III

Product summary

Firm
Mylan Institutional LLC
Event
Event 70375
Status
Terminated
Classification
Class III
Quantity
78,090 vials
Official record key
drug-enforcement:D-0413-2015

Official wording

Reason: Subpotent Drug and Failed Impurities/Degradation Specifications

Code information: Lot #: UW301, UW302, Exp 02/15; UW303, UW304, UW305, UW306, Exp 04/15

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent